Goldman Sachs Adjusts Price Target on GE Healthcare Technologies to $81 From $97, Maintains Buy Rating

Goldman Sachs Adjusts Price Target on GE Healthcare Technologies to $81 From $97, Maintains Buy Rating — alphai